PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.09%
Net income growth at 75-90% of AVGO's 4.77%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
12.15%
Some D&A expansion while AVGO is negative at -1.79%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
14.86%
SBC growth while AVGO is negative at -0.26%. John Neff would see competitor possibly controlling share issuance more tightly.
-109.18%
Negative yoy working capital usage while AVGO is 69.11%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-320.21%
Both yoy AR lines negative, with AVGO at -14.53%. Martin Whitman would suspect an overall sector lean approach or softer demand.
7.33%
Inventory shrinking or stable vs. AVGO's 34.08%, indicating lean supply management. David Dodd would confirm no demand shortfall.
72.73%
AP growth of 72.73% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-75.90%
Negative yoy usage while AVGO is 651.16%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-517.86%
Negative yoy while AVGO is 417.02%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-17.54%
Negative yoy CFO while AVGO is 21.72%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-34.76%
Negative yoy CapEx while AVGO is 15.84%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-50.00%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
38.29%
Purchases growth of 38.29% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
51.41%
Liquidation growth of 51.41% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
730.77%
Growth well above AVGO's 212.50%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
173.44%
We have mild expansions while AVGO is negative at -0.32%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-1.75%
Negative yoy issuance while AVGO is 5800.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-100.68%
Both yoy lines negative, with AVGO at -6.16%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.